Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A pair for PULS
September 2016
SHARING OPTIONS:

IRVINE, Calif.—A new partnership is underway between Global Discovery Biosciences (GD Biosciences) and LifeLabs Medical Laboratory Services to make the PULS Cardiac Test—a blood test that identifies people at risk of a heart attack who could be helped by early intervention—available in Canada. The test measures an individual's immune response to arterial or endothelial injury that leads to the formation and progression of cardiac lesions; the rupture of these lesions causes up to 75 percent of all heart attacks.
 
“We are very pleased to be working with GD Biosciences and making available the PULS test to all Canadians. We all appreciate the benefits of early diagnosis of disease, including heart disease, and the PULS test is further evidence of LifeLabs' commitment to bring new, innovative, clinically useful diagnostics to Canada in our effort to keep Canadians healthy,” remarked Jeff Sumner, LifeLabs' senior vice president, Business Development, Clinical Affairs and Genetics.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.